MUC16 and cancer: In addition, the treatment of tumor necrosis factor-associated apoptosis-inducing ligands (TRAIL) is also a new direction, such as Meso-TR3 of human recombinant TRAIL targeting MUC16 (CA125) that can transport TR3 to cancer cells to play a role [80].